Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1271 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism
Conditions: Progressive Supranuclear Palsy;   Multi-System Atrophy;   Parkinsonism
Intervention: Drug: [F18]-FDDNP
2 Recruiting Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
Condition: Parkinsonism
Interventions: Other: GAITRite;   Other: ADPM
3 Terminated
Has Results
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
Conditions: REM Behavior Disorder;   Parkinsonism
Interventions: Drug: Rozerem;   Drug: Placebo
4 Recruiting 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
Condition: Vascular Parkinsonism
Intervention: Drug: 18F-DTBZ
5 Unknown  Identification, Prevalence, and Lifespan of Rapid-Onset Dystonia-Parkinsonism
Conditions: Dystonia;   Parkinsonism
Intervention:
6 Recruiting To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
Condition: Hepatic/Cirrhosis Related Parkinsonism.
Intervention: Drug: Lactulose+Rifagut+Bromocriptine
7 Recruiting MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Conditions: Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
Intervention:
8 Enrolling by invitation Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Other: no intervention
9 Unknown  Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Parkinsonian Syndrome;   Multiple System Atrophy;   Supranuclear Palsy, Progressive;   Essential Tremor;   Vascular Parkinsonism;   Drug Induced Parkinsonism
Intervention:
10 Unknown  Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
Conditions: Parkinson Disease;   Parkinsonian Disorders
Intervention: Procedure: Biopsy of skin
11 Active, not recruiting Parkinson's Disease, Diagnostic Observations (PADDO)
Conditions: Parkinson's Disease;   Atypical Parkinsonism
Intervention:
12 Enrolling by invitation BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease
Conditions: Parkinsonism, Experimental;   Parkinsonism, Treatment as Usual
Interventions: Behavioral: Body awareness therapy;   Other: Physical therapy
13 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment;   REM Sleep Behavior Disorder
Interventions: Drug: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan);   Device: Single photon emission computed tomography (SPECT) scan
14 Completed Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
15 Completed Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Device: Mobilaser
16 Unknown  Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Conditions: Parkinson Disease;   Parkinsonism;   Seborrheic Dermatitis
Intervention: Drug: Botulinum toxin
17 Active, not recruiting Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Conditions: Progressive Supranuclear Palsy;   Atypical Parkinsonism
Interventions: Drug: Coenzyme Q10;   Drug: CoenzymeQ10
18 Terminated Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Subjects With Schizophrenia (Study P04628)(TERMINATED)
Conditions: Akathisia, Drug-Induced;   Dyskinesia, Drug-Induced;   Parkinsonian Disorders
Interventions: Drug: Preladenant;   Drug: Placebo
19 Enrolling by invitation Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
Conditions: Movement Disorders;   Parkinson Disease;   Parkinsonian Disorders;   Dystonia;   Tourette Syndrome
Intervention: Procedure: Sedation with IV propofol
20 Completed Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Interventions: Drug: AFQ056;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years